Stage A - Precision Medicine - Resistant Hypertension - Hyperaldosteronism PI CME Project
Submit answers to questions for Stage A no later than 11:59 PM on 9/17/2023. You must complete the Stage A submission by this date to receive credit for Stage A and to progress to Stage B
This course is part of the approved PI CME activity, Precision Medicine - Resistant Hypertension - Hyperaldosteronism PI CME Project
Prior to participating in Stage A, physicians should view the video located [HERE] to familiarize themselves the project algorithm.
Stage A: Learning from current practice performance assessment - Assess current practice using the identified performance measures, either through chart reviews or some other appropriate mechanism.
For this project: You have received a report specific to your practice data for the past 6 months with baseline data for individual physician practice based on best practice alert (BPA) as follows:
% of visits with an associated diagnosis of hypertension with uncontrolled HTN
% of visits with the BPA firing suggesting testing for hyperaldosteronism
% of BPA firings where testing was actually completed on their patients
PCP enrolled in the Precision Medicine - Resistant Hypertension - Hyperaldosteronism PI CME Project.
1. Analyze data to determine how many (what percentage of) patients with resistant hypertension present in their practice setting
2. Develop a plan of action based on data analysis for utilization of best practice alert and integration of algorithm
- 5.00 AMA PRA Category 1 Credit™The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
- 5.00 Attendance